Cognitive decline is partly linked to a protein that accumulates in the blood with age, according to a study published Monday, July 6 in the scientific journal NatureMedicine.
The molecule identified as an aging factor is Beta-2 microglubulin (B2M), a component linked to the control of the immune system. It would block the regeneration of cells in the hippocampus, the area of the brain linked to memory.
The scientists studied the brains of older mice and younger mice. They first observed that the transfusion of blood from young individuals into older mice improved their cognitive functions and even restored their memory. In view of these results, they hypothesized that an element of the blood, B2M, could be the cause of cognitive decline. To be sure, they performed the reverse operation and injected blood from older individuals into younger mice. The latter then obtained less good results in the learning and memory tests than the young non-transfused mice, suggesting that the B2M had a negative effect on cognitive functioning and the creation of new neurons.
During additional experiments, the researchers found that the rate of B2M increased with age in mice, but also in humans. The molecule has indeed been found in large quantities in the blood and in the cerebrospinal fluid of the brain in elderly people prone to memory and learning disorders.
However, the effect of this aging factor could well be reversed. In young mice having received blood from old mice, the action of the molecule disappeared after thirty days after the transfusion. The young mice then found cognitive functions normal. The inhibition of the B2M protein, by a drug or by blocking the gene linked to this molecule would make it possible to stop the aging cognitive. The authors are therefore now working on molecular approaches to target this protein in order to block the cerebral aging it causes. A great therapeutic hope on the side of neurodegenerative diseases and dementias such as Alzheimer’s disease.
Read also :
Alzheimer’s: a molecule reverses the loss of cognitive functions in mice
Dementia: to reduce the risk, drink less alcohol
Alzheimer’s disease: a therapeutic molecule identified
